Zoetis (ZTS) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Zoetis Revenue Highlights

Latest Revenue (Y)

$9.26B

Latest Revenue (Q)

$2.39B

Main Segment (Y)

Horses

Main Geography (Y)

United States Segment

Zoetis Revenue by Period

Zoetis Revenue by Year

Date	Revenue	Change
2024-12-31	$9.26B	8.33%
2023-12-31	$8.54B	5.74%
2022-12-31	$8.08B	3.91%
2021-12-31	$7.78B	16.49%
2020-12-31	$6.67B	6.63%
2019-12-31	$6.26B	7.47%
2018-12-31	$5.83B	9.76%
2017-12-31	$5.31B	8.57%
2016-12-31	$4.89B	2.58%
2015-12-31	$4.76B	-0.42%
2014-12-31	$4.79B	4.91%
2013-12-31	$4.56B	5.19%
2012-12-31	$4.34B	2.43%
2011-12-31	$4.23B	18.17%
2010-12-31	$3.58B	29.78%
2009-12-31	$2.76B	-

Zoetis generated $9.26B in revenue during NA 2024, up 8.33% compared to the previous quarter, and up 147.86% compared to the same period a year ago.

Zoetis Revenue by Quarter

Date	Revenue	Change
2024-09-30	$2.39B	1.14%
2024-06-30	$2.36B	7.81%
2024-03-31	$2.19B	-1.04%
2023-12-31	$2.21B	2.88%
2023-09-30	$2.15B	-1.33%
2023-06-30	$2.18B	9.00%
2023-03-31	$2.00B	-1.96%
2022-12-31	$2.04B	1.90%
2022-09-30	$2.00B	-2.44%
2022-06-30	$2.05B	3.32%
2022-03-31	$1.99B	0.97%
2021-12-31	$1.97B	-1.16%
2021-09-30	$1.99B	2.16%
2021-06-30	$1.95B	4.12%
2021-03-31	$1.87B	3.54%
2020-12-31	$1.81B	1.18%
2020-09-30	$1.79B	15.37%
2020-06-30	$1.55B	0.91%
2020-03-31	$1.53B	-8.36%
2019-12-31	$1.67B	5.68%
2019-09-30	$1.58B	2.39%
2019-06-30	$1.55B	6.32%
2019-03-31	$1.46B	-6.97%
2018-12-31	$1.56B	5.68%
2018-09-30	$1.48B	4.59%
2018-06-30	$1.42B	3.59%
2018-03-31	$1.37B	-6.44%
2017-12-31	$1.46B	8.39%
2017-10-01	$1.35B	6.15%
2017-07-02	$1.27B	3.09%
2017-04-02	$1.23B	-3.60%
2016-12-31	$1.28B	2.90%
2016-10-02	$1.24B	2.73%
2016-07-03	$1.21B	3.96%
2016-04-03	$1.16B	-8.79%
2015-12-31	$1.27B	4.94%
2015-09-27	$1.21B	3.32%
2015-06-28	$1.18B	6.62%
2015-03-29	$1.10B	-16.52%
2014-12-31	$1.32B	9.09%
2014-09-28	$1.21B	4.49%
2014-06-29	$1.16B	5.56%
2014-03-30	$1.10B	-12.52%
2013-12-31	$1.25B	13.69%
2013-09-29	$1.10B	-0.99%
2013-06-30	$1.11B	2.20%
2013-03-31	$1.09B	-7.31%
2012-12-31	$1.18B	15.41%
2012-09-30	$1.02B	-6.86%
2012-06-30	$1.09B	4.49%
2012-03-31	$1.05B	-7.10%
2011-12-31	$1.13B	7.44%
2011-09-30	$1.05B	-2.33%
2011-06-30	$1.07B	9.26%
2011-03-31	$983.00M	-

Zoetis generated $2.39B in revenue during Q3 2024, up 1.14% compared to the previous quarter, and up 109.54% compared to the same period a year ago.

Zoetis Revenue Breakdown

Zoetis Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Poultry	$527.00M	$524.00M	-	-	-
Cattle	$1.53B	$1.50B	-	-	-
Dogs and Cats	$285.00M	$285.00M	-	-	-
Fish	$242.00M	$220.00M	-	-	-
Horses	$5.99B	$5.29B	-	-	-
Swine	$516.00M	$543.00M	-	-	-
Anti-infective Products	-	$1.06B	-	-	-
Animal Health Diagnostics	-	$376.00M	-	-	-
Other Pharmaceuticals	-	$1.28B	-	-	-
Other Non Pharmaceuticals	-	$254.00M	-	-	-
Medicated Feed Additives	-	$354.00M	-	-	-
Dermatology	-	$1.43B	-	-	-
Contract Manufacturing and Human Health Diagnostics	-	$78.00M	$86.00M	$82.00M	$83.00M
Vaccines	-	$1.77B	-	-	-
Total Products and Services	-	$8.47B	-	-	-
Parasiticides	-	$1.95B	-	-	-

Zoetis's latest annual revenue breakdown by segment (product or service), as of Dec 24: Horses (65.90%), Cattle (16.84%), Poultry (5.80%), Swine (5.67%), Dogs and Cats (3.13%), and Fish (2.66%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Dogs and Cats	-	$1.55B	$1.38B	-	$1.35B	$1.42B	$1.15B	$-3.45B	$1.21B	$1.30B	$1.20B	$-3.06B	$1.14B	$1.16B	$1.02B	$-2.31B	-	-	-	-
Swine	$258.00M	$131.00M	$127.00M	$139.00M	$129.00M	$133.00M	$142.00M	$138.00M	$129.00M	$144.00M	$154.00M	$155.00M	$153.00M	$161.00M	$190.00M	$167.00M	-	-	-	-
Poultry	$249.00M	$139.00M	$139.00M	$127.00M	$127.00M	$131.00M	$139.00M	$115.00M	$116.00M	$121.00M	$124.00M	$118.00M	$124.00M	$134.00M	$131.00M	$125.00M	-	-	-	-
Horses	$5.87B	$58.00M	$66.00M	$5.09B	$60.00M	$65.00M	$72.00M	$4.75B	$58.00M	$63.00M	$64.00M	$4.24B	$60.00M	$68.00M	$60.00M	$3.29B	-	-	-	-
Fish	$127.00M	$70.00M	$45.00M	$62.00M	$57.00M	$52.00M	$49.00M	$61.00M	$60.00M	$47.00M	$44.00M	$55.00M	$56.00M	$39.00M	$37.00M	$47.00M	-	-	-	-
Cattle	$749.00M	$391.00M	$391.00M	$401.00M	$374.00M	$329.00M	$399.00M	$377.00M	$371.00M	$328.00M	$364.00M	$413.00M	$403.00M	$342.00M	$399.00M	$451.00M	-	-	-	-
Other Pharmaceuticals	-	-	-	$358.00M	$313.00M	$315.00M	$294.00M	$272.00M	$252.00M	$265.00M	$254.00M	$249.00M	$243.00M	$248.00M	$226.00M	$224.00M	$208.00M	$192.00M	$197.00M	-
Parasiticides	-	-	-	$947.00M	$568.00M	$432.00M	$443.00M	$422.00M	$536.00M	$459.00M	$389.00M	$396.00M	$460.00M	$390.00M	$306.00M	-	-	-	-	-
Total Products and Services	-	-	-	$4.32B	$2.16B	$1.98B	$2.01B	$1.98B	$2.03B	$1.97B	$1.94B	$1.97B	$1.93B	$1.85B	$1.78B	-	-	-	-	-
Vaccines	-	-	-	$912.00M	$430.00M	$429.00M	$418.00M	$449.00M	$446.00M	$405.00M	$422.00M	$421.00M	$417.00M	$413.00M	$390.00M	-	-	-	-	-
Animal Health Diagnostics	-	-	-	$187.00M	$96.00M	$93.00M	$85.00M	$83.00M	$87.00M	$98.00M	$91.00M	$95.00M	$99.00M	$89.00M	$89.00M	-	-	-	-	-
Anti-infective Products	-	-	-	$525.00M	$244.00M	$288.00M	$279.00M	$284.00M	$233.00M	$285.00M	$306.00M	$329.00M	$259.00M	$321.00M	$336.00M	-	-	-	-	-
Dermatology	-	-	-	$776.00M	$359.00M	$292.00M	$351.00M	$348.00M	$319.00M	$311.00M	$321.00M	$326.00M	$285.00M	$248.00M	$260.00M	-	-	-	-	-
Medicated Feed Additives	-	-	-	$183.00M	$84.00M	$87.00M	$99.00M	$78.00M	$85.00M	$98.00M	$106.00M	$99.00M	$103.00M	$112.00M	$124.00M	-	-	-	-	-
Other Non Pharmaceuticals	-	-	-	$122.00M	$64.00M	$68.00M	$66.00M	$63.00M	$63.00M	$58.00M	$58.00M	$60.00M	$57.00M	$56.00M	$55.00M	-	-	-	-	-
Manufactured Product, Other	-	-	-	-	$29.00M	$26.00M	$29.00M	$19.00M	$32.00M	$28.00M	$19.00M	$19.00M	$31.00M	$23.00M	$22.00M	$16.00M	-	-	-	-
Livestock	-	-	-	-	$716.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Companion Animal	-	-	-	-	$1.41B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract Manufacturing and Human Health Diagnostics	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$22.00M

Zoetis's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Horses (80.93%), Cattle (10.33%), Swine (3.56%), Poultry (3.43%), and Fish (1.75%).

Zoetis Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
UNITED KINGDOM	$954.00M	$864.00M	-	-	-
AUSTRALIA	$319.00M	$323.00M	$289.00M	$259.00M	$207.00M
United States Segment	$5.35B	$4.81B	-	-	-
JAPAN	$417.00M	$478.00M	$173.00M	$186.00M	$177.00M
MEXICO	$706.00M	$695.00M	$136.00M	$133.00M	$116.00M
BRAZIL	-	$393.00M	$330.00M	$312.00M	$258.00M
UNITED STATES	-	$4.55B	$4.31B	$4.04B	$3.56B
Total Geographical Area	-	$8.47B	$7.99B	$7.69B	$6.59B
SPAIN	-	$122.00M	$118.00M	$128.00M	$112.00M
ITALY	-	$121.00M	$111.00M	$115.00M	$90.00M
GERMANY	-	$202.00M	$176.00M	$183.00M	$159.00M
FRANCE	-	$142.00M	$126.00M	$132.00M	$118.00M
CHINA	-	$320.00M	$382.00M	$357.00M	$266.00M
CHILE	-	$140.00M	$141.00M	$136.00M	$100.00M
CANADA	-	$255.00M	$238.00M	$232.00M	$210.00M

Zoetis's latest annual revenue breakdown by geography, as of Dec 24: United States Segment (69.07%), UNITED KINGDOM (12.31%), MEXICO (9.11%), JAPAN (5.38%), and AUSTRALIA (4.12%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
United States Segment	$2.71B	$1.41B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
MEXICO	$359.00M	$171.00M	$44.00M	$43.00M	$42.00M	$38.00M	$39.00M	$35.00M	$33.00M	$33.00M	$35.00M	$35.00M	$31.00M	$34.00M	$33.00M	$32.00M	$26.00M	$26.00M	$32.00M	$30.00M
UNITED KINGDOM	$563.00M	$239.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
JAPAN	$210.00M	$94.00M	$37.00M	$38.00M	$34.00M	$47.00M	$39.00M	$36.00M	$37.00M	$41.00M	$59.00M	$46.00M	$43.00M	$50.00M	$47.00M	$44.00M	$39.00M	$53.00M	$41.00M	$40.00M
AUSTRALIA	$163.00M	$83.00M	$73.00M	$75.00M	$84.00M	$82.00M	$82.00M	$64.00M	$80.00M	$80.00M	$65.00M	$63.00M	$70.00M	$69.00M	$57.00M	$53.00M	$60.00M	$51.00M	$43.00M	$46.00M
UNITED STATES	-	-	$1.16B	$1.21B	$1.17B	$1.17B	$1.00B	$1.11B	$1.09B	$1.09B	$1.02B	$1.04B	$1.06B	$1.00B	$933.00M	$952.00M	$996.00M	$823.00M	$786.00M	$861.00M
Total Geographical Area	-	-	$2.17B	$2.19B	$2.13B	$2.16B	$1.98B	$2.01B	$1.98B	$2.03B	$1.97B	$1.94B	$1.97B	$1.93B	$1.85B	$1.78B	$1.76B	$1.53B	$1.51B	$1.65B
ITALY	-	-	$28.00M	$34.00M	$26.00M	$35.00M	$26.00M	$25.00M	$24.00M	$32.00M	$30.00M	$28.00M	$30.00M	$32.00M	$25.00M	$27.00M	$28.00M	$14.00M	$21.00M	$30.00M
GERMANY	-	-	$51.00M	$54.00M	$50.00M	$53.00M	$45.00M	$44.00M	$43.00M	$46.00M	$43.00M	$48.00M	$47.00M	$50.00M	$38.00M	$47.00M	$38.00M	$40.00M	$34.00M	$42.00M
SPAIN	-	-	$32.00M	$28.00M	$30.00M	$31.00M	$33.00M	$21.00M	$29.00M	$35.00M	$33.00M	$31.00M	$33.00M	$33.00M	$31.00M	$29.00M	$31.00M	$24.00M	$28.00M	$28.00M
FRANCE	-	-	$41.00M	$40.00M	$34.00M	$34.00M	$34.00M	$35.00M	$28.00M	$31.00M	$32.00M	$34.00M	$31.00M	$32.00M	$35.00M	$36.00M	$29.00M	$24.00M	$29.00M	$34.00M
CHINA	-	-	$76.00M	$65.00M	$69.00M	$84.00M	$102.00M	$91.00M	$92.00M	$96.00M	$103.00M	$68.00M	$72.00M	$94.00M	$123.00M	$68.00M	$66.00M	$66.00M	$66.00M	$44.00M
CHILE	-	-	$31.00M	$31.00M	$31.00M	$39.00M	$39.00M	$35.00M	$31.00M	$34.00M	$41.00M	$36.00M	$32.00M	$34.00M	$34.00M	$28.00M	$24.00M	$25.00M	-	-
CANADA	-	-	$61.00M	$72.00M	$63.00M	$70.00M	$50.00M	$66.00M	$56.00M	$67.00M	$49.00M	$63.00M	$56.00M	$67.00M	$46.00M	$66.00M	$50.00M	$54.00M	$40.00M	$64.00M
BRAZIL	-	-	$101.00M	$117.00M	$101.00M	$91.00M	$84.00M	$97.00M	$70.00M	$86.00M	$77.00M	$85.00M	$78.00M	$75.00M	$74.00M	$77.00M	$62.00M	$56.00M	$63.00M	$87.00M

Zoetis's latest quarterly revenue breakdown by geography, as of Dec 24: United States Segment (67.71%), UNITED KINGDOM (14.04%), MEXICO (8.95%), JAPAN (5.24%), and AUSTRALIA (4.06%).

Zoetis Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TAK	Takeda Pharmaceutical	$4.26T	$1.05T
TEVA	Teva Pharmaceutical Industries	$16.54B	$4.33B
VTRS	Viatris	$14.74B	$3.74B
HLN	Haleon	$11.30B	$2.92B
BHC	Bausch Health Companies	$9.52B	$2.51B
ZTS	Zoetis	$9.26B	$2.39B
ELAN	Elanco Animal Health	$4.44B	$1.18B
NBIX	Neurocrine Biosciences	$2.36B	$622.10M
EBS	Emergent BioSolutions	$1.04B	$254.70M
AMPH	Amphastar Pharmaceuticals	$712.81M	$188.82M
ITCI	Intra-Cellular Therapies	$680.85M	$175.38M
ASRT	Assertio	$124.96M	$29.20M
ALVO	Alvotech	$91.43M	$12.43M

ZTS Revenue FAQ

What is Zoetis’s yearly revenue?

Zoetis's yearly revenue for 2024 was $9.26B, representing an increase of 8.33% compared to 2023. The company's yearly revenue for 2023 was $8.54B, representing an increase of 5.74% compared to 2022. ZTS's yearly revenue for 2022 was $8.08B, representing an increase of 3.91% compared to 2021.

What is Zoetis’s quarterly revenue?

Zoetis's quarterly revenue for Q3 2024 was $2.39B, a 1.14% increase from the previous quarter (Q2 2024), and a 11.02% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.36B, a 7.81% increase from the previous quarter (Q1 2024), and a 8.30% increase year-over-year (Q2 2023). ZTS's quarterly revenue for Q1 2024 was $2.19B, a -1.04% decrease from the previous quarter (Q4 2023), and a 9.50% increase year-over-year (Q1 2023).

What is Zoetis’s revenue growth rate?

Zoetis's revenue growth rate for the last 3 years (2022-2024) was 14.55%, and for the last 5 years (2020-2024) was 38.67%.

What are Zoetis’s revenue streams?

Zoetis's revenue streams in c 24 are Poultry, Cattle, Dogs and Cats, Fish, Horses, and Swine. Poultry generated $527M in revenue, accounting 5.80% of the company's total revenue, up 0.57% year-over-year. Cattle generated $1.53B in revenue, accounting 16.84% of the company's total revenue, up 1.86% year-over-year. Dogs and Cats generated $285M in revenue, accounting 3.13% of the company's total revenue Fish generated $242M in revenue, accounting 2.66% of the company's total revenue, up 10.00% year-over-year. Horses generated $5.99B in revenue, accounting 65.90% of the company's total revenue, up 13.27% year-over-year. Swine generated $516M in revenue, accounting 5.67% of the company's total revenue, down -4.97% year-over-year.

What is Zoetis’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Zoetis was Horses. This segment made a revenue of $5.99B, representing 65.90% of the company's total revenue.